Hyperglycemic memory occurs in diabetic cardiovascular complications, but the underlying mechanism remains to be elucidated. Although the depletion of SET8 leads to increased mitochondrial oxidative stress via increasing cellular reactive oxygen species (ROS) production, the role of SET8 in hyperglycemic memory-induced mitochondrial dysfunction is not well understood. Here, we investigated the role of SET8 in this setting. Our results showed that high glucose-induced vascular inflammation, ROS production and apoptosis remained at high levels even when glucose returned to normal level. Elevated glucose reduced SET8 expression, which also remained at low level after returning to normoglycemia. SET8 overexpression protected cells from elevated glucose and hyperglycemic memory-induced endothelial injury by blocking ROS accumulation, attenuating vascular inflammation, and restoring nitric oxide production. Thus, our results suggest that SET8 may be a key mediator in hyperglycemic memory.
Introduction
The prevalence of diabetes has been increasing over the past decades, posing a growing public health problem worldwide [1] . Morbidity and mortality of cardiovascular complications from hyperglycemia in patients with diabetes remain high despite great efforts have been made to treat the disease [2] . Studies from the Diabetes Control and Complications Trial (DCCT) showed that the influence of hyperglycemia could persist during the period of hyperglycemia control, and restoration of blood glucose failed to reduce the outcome of cardiovascular complications [3, 4] . The persistence of hyperglycemic stress after normalization of blood glucose has been referred to as 'hyperglycemic memory'. Although numerous signaling pathways have been identified to prevent diabetic vascular disease, this metabolic memory phenomenon remains poorly understood.
Excessive production of mitochondrial reactive oxygen species (ROS) has been suggested as a unifying hypothesis in the development of diabetic complications [5] [6] [7] . Ihnat et al. [8] demonstrated a role of ROS in mediating persistent vascular stress after glucose normalization. This was consistent with other observations that cells continued to show elevated expression of fibronectin even after subsequent exposure to normoglycemia [9] . Hyperglycemia was found to inhibit sirtuin-1 expression in endothelial cells and was related to cellular metabolic memory of elevated glucose [10] . Hyperglycemia in endothelial cells decreases the availability of nitric oxide (NO) and triggers vascular inflammation. However, whether hyperglycemia induces mitochondrial ROS production remains to be clarified. SET8, also known as KMT5A, is the only known lysine methyltransferase involved in the monomethylation of lysine 20 of histone H4 (H4K20) [11] . The methyltransferase activity of the enzyme is implicated in multiple essential cellular pathways, including DNA replication, cell cycle regulation, genomic instability, transcriptional modulation, and cellular metabolism [11, 12] . It was recently found that SET8 functioned as a barrier in mitochondrial OXPHO activity and ROS accumulation, thereby leading to cell senescence [13] . Epigenetic changes have been found to be responsible for sustained gene expression in hyperglycemic memory [7, 14] . Based on this background, we hypothesize that SET8 may play a major role in the phenomenon of hyperglycemia-induced metabolic memory.
In the present study, we demonstrated the endothelial dysfunction induced by hyperglycemia and its persistence after glucose normalization. This metabolic memory of hyperglycemia led to decreased expression of SET8. We also explored whether SET8 can reverse the endothelial dysfunction induced by hyperglycemia via induction of SET8 expression in endothelial cells.
Materials and Methods

Cell culture
Human umbilical vein endothelial cells (HUVECs) were obtained from American Type Culture Collection (ATCC; Manassas, USA) and maintained in Dulbecco's modified Eagle medium (DMEM) with 5 mM glucose and 10% fetal bovine serum. Cells were cultured in a humidified incubator with 5% CO 2 at 37°C. Cells were used at passages 3-5 for experiments.
Monocyte-endothelial adhesion assay
HUVECs were grown in 24-well plates to a proper confluence. THP-1 cells were isolated from peripheral blood of healthy individuals and labeled with Calcein-AM (Beyotime Biotechnology, Shanghai, China) at 37°C for 1 h. After centrifugation (1000 g, 5 min) and washing with phosphate buffered saline (PBS), Calcein-AM labeled THP-1 cells were then co-incubated with HUVECs for 1 h at 37°C. Non-adherent THP-1 cells were washed away with PBS twice. Images of adherent cells were captured under a fluorescence microscope (OLYMPUS, Tokyo, Japan). Each experiment was performed in triplicate.
Apoptosis assay
Apoptosis was determined by fluorescence-activated cell sorting (FACS) analysis (Cytomics FC 500MPL; Beckman Coulter, Fullerton, USA) using double staining with Annexin V-FITC and propidium iodide (PI; BD Biosciences, San Jose, USA) according to the manufacturer's instructions. Briefly, following different treatments, cells were harvested and incubated with PI and Annexin V-FITC for 30 min at 37°C in the dark and then subject to FACS analysis. Each experiment was performed in triplicate.
Western blot analysis
Cell lysate was collected using cell lysis buffer (Cell Signaling Technology, Danvers, USA) containing 1% protease inhibitor cocktail (Roche, Paris, France) and phosphatase inhibitor (Sigma, St Louis, USA). Then, cell lysates were sonicated using Vibra-Cell Sonifier (Sonics and Materials, Newtown, USA) setting at 32% amplitude for three times (5 s each, with at least 1 min of rest on ice pulses) and clarified by centrifugation at 12,000 g for 15 min. Solubilized proteins (30 μg) were subject to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blot analysis using antibodies against ICAM-1 (ProteinTech, Wuhan, China; 10831-1-AP, 1/1000), VCAM-1 (ProteinTech; 11444-1-AP, 1/1000), E-Selectin (ProteinTech; 20894-1-AP, 1/1000), Caspase 3 (ProteinTech; 19677-1-AP, 1/1000), SET8 (ProteinTech; 14063-1-AP, 1/1000), and β-actin (ProteinTech; 60008-1-AP, 1/5000). Immunoreactive bands were detected using horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, USA; 1/ 1000) in the presence of enhanced chemiluminescence substrate. Loading of the protein samples was normalized to β-actin. Each experiment was performed in triplicate.
Quantitative real-time PCR (qPCR)
Total RNA was extracted using Trizol reagent (Tiangen Biotech, Beijing, China). cDNA was prepared using a TaKaRa PrimeScript reagent kit with gDNA Eraser (Dalian, China). Approximately 100 ng cDNA was used for each PCR reaction performed with QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems, Life Technologies, Waltham, USA). Primer sequences are listed in Table 1 . Each experiment was performed in triplicate.
Plasmid construction and transfection
The Flag-tagged coding sequence of human SET8 was cloned into the lentiviral vector pPCDH-CMV-MCS-EF1-puro to generate SET8 expression plasmid. SET8 plasmid was transfected into HUVECs using Lipofectamine 2000 (Invitrogen, Waltham, USA) according to the manufacturer's instructions. Briefly, endothelial cells were treated with high glucose for 6 days or high glucose for 3 days, followed by 3 days of treatment with normal glucose media, and then SET8 plasmid was transfected into endothelial cells using Lipofectamine 2000. At 48 h after transfection, cells were harvested for western blot and qPCR analysis, and then subject to subsequent experiments. Each experiment was performed in triplicate.
Assessment of ROS
Cellular ROS was measured using Reactive Oxygen Species Assay kit (Beyotime Biotechnology). Briefly, cells were washed with PBS three times and then incubated with 5 μM DCFH-DA at 37°C for Table 1 . Sequence of primers used in this study
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Forward Reverse
30 min. Then, cells were washed with DMEM without FBS three times, and then analyzed by flow cytometry at 488 nm excitation and 520 nm emission. Each experiment was performed in triplicate.
Oxygen consumption rate
Cellular mitochondrial function was measured using the Seahorse XF Cell Mito stress test kit (Agilent, Santa Clara, USA) according to the manufacturer's instructions. Cells were trypsinized and then cultured in the assay plate for 24 h prior to the assay. Inhibitors of respiratory chain components were serially added to the culture medium during the measurement, including the ATP synthase inhibitor, oligomycin (1 μM), the respiratory uncoupler, carbonyl cyanidep-(trifluoromethoxy) phenylhydrazone (FCCP) (1.5 μM), and the complex I and III inhibitors, rotenone (1 μM), and antimycin (1 μM). Oxygen consumption rate (OCR) values were measured 6 times and calculated after normalization to cell count. Each experiment was performed in triplicate.
Measurement of NO production
NO production was estimated by measuring the concentrations of nitrate and nitrite, the stable metabolites of NO, according to the Griess assay using the Total Nitric Oxide Assay kit (Beyotime Biotechnology). Each experiment was performed in triplicate.
Mitochondrial membrane potential assay
The mitochondrial membrane potential (Δψm) was measured using a Mitochondrial membrane potential assay kit with JC-1 (Beyotime Biotechnology). Briefly, cells were harvested and resuspended in 0.5 ml of culture medium. Then, 0.5 ml of JC-1 staining solution was added to the suspension and incubated for 20 min at 37°C. Next, cells were collected by centrifugation at 600 g for 4 min. The cell pellet was washed with JC-1 staining buffer twice, and then resuspended in 500 μl JC-1 staining buffer. The samples were immediately analyzed by flow cytometry. In healthy cells, JC-1 forms mitochondrial aggregates, emitting red fluorescence at 595 nm when excited at 525 nm. However, after loss of Δψm, JC-1 remains as monomers emitting green fluorescence at 525 nm when excited at 485 nm. Mitochondrial depolarization is indicated by a decrease in the red/green fluorescence intensity ratio. Each experiment was performed in triplicate.
Statistical analysis
Data are presented as the mean ± SD from three replicates. All data were processed by SPSS software (version 22.0). Student's t test and one-way analysis of variance were used to determine the statistical differences among different treatments. A P-value <0.05 was considered statistically significant.
Results
High glucose-induced endothelial adhesion and apoptosis of HUVECs and their persistence under normoglycemia
To explore whether hyperglycemia could induce persistent dysfunction of HUVECs, the cells were subcultured in three different types of media: normal glucose (Con, 5 mM, 6 days), high glucose (HG, 25 mM, 6 days), and high glucose followed by normal glucose media (HN, 3 days of high glucose and 3 days of normal glucose). Results showed that high glucose increased cellular adhesion ability of monocytes to HUVECs, and expressions of adhesion molecules (ICAM-1, VCAM-1, and E-Selectin) were elevated after exposure to high glucose (Fig. 1A,B) . The effects of high glucose were persistent even after glucose normalization (HN) (Fig. 1A,B) . We then examined the effect of high glucose and glucose normalization after high glucose on cell apoptosis and NO production. Compared with the control group, cells exposed to HG and HM led to a significant increase of cell apoptosis (Fig. 1C) . Consistent with cell apoptosis, high glucose impaired NO release and restoration of normal glucose levels did not improve the bioavailability of NO (Fig. 1D) . Together, these results suggest a memory of hyperglycemia on endothelial dysfunction.
High glucose and hyperglycemia memory-induced oxidative stress of HUVECs
To determine whether high glucose induces vascular oxidative stress, ROS generation in the three groups of HUVECs were measured. As shown in Fig. 2A , continuous exposure to high glucose resulted in sustained increase of ROS generation. Furthermore, ROS generation remained at elevated level after restoration to normal glucose levels. Next, we investigated Δψm with fluorescent JC-1 staining. The ratio of aggregated and monomeric forms of JC-1 dye indicates mitochondrial membrane potential. The results revealed that both high glucose and hyperglycemia memory led to reduced mitochondrial membrane potential of HUVECs (Fig. 2B) . Consistent with decreased Δψm, increased mitochondrial OCR was also observed in cells exposed to high glucose and hyperglycemic memory (Fig. 2C ).
Decreased expression of SET8 induced by high glucose and its persistence after glucose normalization
After exposure to high glucose, significant downregulation of both mRNA and protein levels of SET8 were found (Fig. 3A) . Interestingly, the decreased expression of SET8 persisted even after 3 days of glucose normalization. Because SET8 is a histone methyltransferase specifically involved in monomethylation of H4K20, we examined the expression of H4K20me1 in HUVECs after treatment with high glucose and hyperglycemic memory. As shown in Fig. 3B , H4K20me1 expression was also decreased in high glucose-treated HUVECs. To explore the mechanism by which SET8 is involved in high glucose and hyperglycemic memory-induced dysfunction of HUVECs, SET8 overexpression plasmid was used to activate SET8 in HUVECs exposed to high glucose and hyperglycemic memory. As shown in Fig. 3C ,D, both mRNA and protein levels of SET8 were significantly elevated in cells overexpressing SET8.
SET8 inhibits oxidative stress induced by high glucose and hyperglycemia memory
As described above, high glucose led to a significant decrease of SET8 at the mRNA and protein levels, which remained at decreased level after glucose normalization. To elucidate the relevance of SET8 in hyperglycemic stress, we first measured ROS generation in cells overexpressing SET8. Figure 4A shows that SET8 blocked ROS accumulation induced by hyperglycemic stress. Similarly, the ratio of aggregated and monomeric forms of JC-1 indicated that SET8 reversed mitochondrial membrane potential induced by high glucose and even after glucose normalization (Fig. 4B) . To further confirm this, we assessed the role of SET8 in high glucose-induced mitochondrial OCR. In line with ROS and Δψm, overexpression of SET8 also significantly decreased mitochondrial OCR induced by hyperglycemic stress (Fig. 4C) .
SET8 restores endothelial dysfunction induced by high glucose and hyperglycemic memory
To further explore the role of SET8 in hyperglycemic stress-induced endothelial dysfunction, we examined the cellular adhesion ability of monocytes to HUVECs overexpressing SET8. As shown in Fig. 5A , the increased cellular adhesion ability was blocked by SET8 in both high glucose and hyperglycemic memory settings. The expressions of adhesion molecules (ICAM-1, VCAM-1, and E-Selectin) were also restored to normal levels in cells overexpressing SET8 (Fig. 5B) . We then investigated whether overexpression of SET8 could affect hyperglycemiainduced cellular apoptosis and NO production. The results showed that SET8 overexpression led to a significant decrease in hyperglycemiainduced cellular apoptosis (Fig. 5C ). In accordance with cellular apoptosis, hyperglycemia-induced reduction of NO release was also reversed in SET8 overexpressing cells (Fig. 5D) .
Discussion
Hyperglycemia remains a major factor in cardiovascular complications, leading to increased morbidity and mortality in the diabetic population [15] . Results from several clinical trials revealed long-lasting detrimental effects to the vessel wall as a result of hyperglycemia, from which the concept of hyperglycemic memory was developed [3, [16] [17] [18] . Since the first report based on retinal findings in diabetic dogs [19] , major efforts have been made to elucidate the potential mechanisms underlying this cellular metabolic memory phenomenon induced by hyperglycemia. Hyperglycemia-induced oxidative stress is the main reason for endothelial dysfunction, characterized by inactivation of the mitochondrial electron transport chain and activation of NADPH oxidase 2 and uncoupled endothelial NO synthase, producing superoxide anion and subsequently other ROS [20] [21] [22] . To date, studies exploring glucose and epigenetic changes have demonstrated the role of ROS generation, which plays a central role in diabetic complications and hyperglycemic memory [8, 23] . Therefore, we focused on exploring whether SET8 mono-methyltransferase is involved in this metabolic memory induced by hyperglycemia. To our knowledge, the present study demonstrated for the first time that SET8 confers resistance to the cellular metabolic memory induced by high glucose. We first confirmed that high glucose could induce endothelial dysfunction, and the effect was persisted after restoring to normal glucose. Interestingly, in HUVECs, we observed a decreased expression of SET8 induced by high glucose, and this was persisted even after glucose normalization. Furthermore, activation of SET8 reduced the deleterious metabolic memory of high glucose in endothelial cells. SET8 protected endothelial cells from metabolic memory in response to high glucose via blocking ROS generation, attenuating cell apoptosis, and restoring NO bioavailability. These results suggest a relationship between the reduced level of SET8 and the cellular metabolic memory of high glucose. Studies in the past decade have reported a role for SET8 in the epigenetic regulation of genes involved in many cellular processes [24] [25] [26] . However, the role of SET8 in hyperglycemia remains elusive.
Increased oxidative stress is a main contributor to hyperglycemiainduced vascular complications in diabetic patients [27] [28] [29] . Mitochondrial ROS play an important role in high glucose-induced endothelial cell apoptosis. In this study, we observed the effect of high glucose on apoptosis and confirmed increasing ROS accumulation in endothelial cells exposed to high glucose. Recently, it was proposed that mitochondrial ROS may be related to the persistent detrimental effects of hyperglycemia stress in endothelial cells [8, 10, 30] . Consistent with other previous studies, ROS accumulation was found to be sustained in endothelial cells exposed to high glucose even after 3 days exposure to normoglycemia. Moreover, cell apoptosis remained at increased level in cells after glucose normalization. We also investigated mitochondrial membrane potential, another feature of mitochondrial dysfunction, in cells exposed to hyperglycemic stress. JC-1 fluorescence staining showed a decreased ratio of aggregated/monomeric form of JC-1 in hyperglycemic cells, indicating the effect of high glucose/hyperglycemic memory on mitochondrial dysfunction. In addition, we found that glucose normalization did not reverse high glucose-induced mitochondrial OCR.
Bioavailability of NO is a key factor of normal vascular characteristics [22, 31] . Endothelial dysfunction, represented by impaired NO release, occurs in most cellular and experimental models of diabetes [32] [33] [34] . Similarly, in the present study, we showed that hyperglycemia induced a decrease in NO production, and glucose normalization did not restore normal NO release. Endothelium-derived adhesion molecules play a pivotal role in vascular inflammation [35, 36] . To further confirm the endothelial dysfunction induced by hyperglycemia, we conducted a monocyte adhesion assay and detected the expressions vascular adhesion molecules in hyperglycemic stress. High glucose resulted in increased inflammation in endothelial cells, via the increased vascular adhesion ability and augmented expressions of ICAM-1, VCAM-1, and E-Selectin.
Emerging evidence shows that epigenetic changes that modulate transcription of ROS production and proinflammatory factors play a vital role in maintaining the metabolic memory phenomenon in diabetes [37] . Okabe et al. [14] discovered that H3K4 methyltransferase was responsible for sustained vascular gene expression in the phenomenon of hyperglycemia memory [14] . Another study indicated that high glucose inhibited the expression of class III histone deacetylase sirtuin 1 (SIRT1) and restoration of glucose did not change this inhibition. Importantly, activation of SIRT1 mediated the cellular metabolic memory induced by hyperglycemia via LKB/ AMPK/ROS pathway [10] . A recent study reported that depletion of SET8 triggered mitochondrial activities by increasing intracellular levels of ROS, mitochondrial membrane potential, and OCR [13] . However, the role of SET8 in hyperglycemic memory remains unknown. Interestingly, we found that high glucose attenuated the expression of SET8 and the effect persisted after glucose normalization, suggesting the involvement of SET8 in hyperglycemic memory. To investigate this possible role for SET8, we activated SET8 under conditions of high glucose and hyperglycemic memory. We found that overexpression of SET8 abolished the cellular memory of hyperglycemic stress through at least two mechanisms: attenuation of mitochondrial oxidative stress and suppression of production of inflammatory genes. SET8 overexpression decreased ROS accumulation, cellular apoptosis, and adhesion ability induced by hyperglycemic stress. Moreover, SET8 restored the NO availability impaired by high glucose.
In conclusion, our results showed that SET8 mono-methyltransferase plays an important role in mediating the cellular metabolic memory of hyperglycemia. High glucose induced an increased level of vascular inflammation, ROS production, and decreased level of NO release. These are the effects of high glucose on endothelial cells sustained after glucose normalization, known as hyperglycemic memory. Moreover, hyperglycemic stress attenuated the expression of SET8, and activation of SET8 reversed the detrimental effects of metabolic memory in endothelial cells. These findings may help to better clarify the mechanism of hyperglycemic memory in diabetes and assist in defining therapeutic targets for vascular complications induced by hyperglycemic memory. However, the mechanisms underlying the role of SET8 in inhibiting mitochondrial ROS and epigenetic modulation of genes involved in this metabolic memory still remain to be further investigated. In addition, these in vitro results need to be further verified in an in vivo animal (mouse) model of hyperglycemic memory.
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